Načítá se...
Screening of Cardiovascular Disease in Nonalcoholic Fatty Liver Disease: Whom and How?
Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Patients with NAFLD are at a higher risk of developing cardiovascular disease (CVD). In fact, CVD-related mortality is more common in patients with NAFLD in comparison to liver-related mortality. This association is...
Uloženo v:
| Vydáno v: | J Clin Exp Hepatol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6728527/ https://ncbi.nlm.nih.gov/pubmed/31516267 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jceh.2019.02.005 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|